SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-118452
Filing Date
2024-10-29
Accepted
2024-10-29 19:38:18
Documents
1
Period of Report
2024-10-22

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4969
  Complete submission text file 0000950170-24-118452.txt   7153
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9922 JEFFERSON BOULEVARD CULVER CITY CA 90232
Business Address
SOON-SHIONG PATRICK (Reporting) CIK: 0001189020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39468 | Film No.: 241407077

Mailing Address 9922 JEFFERSON BOULEVARD CULVER CITY CA 90232
Business Address 310-836-6400
Nant Capital, LLC (Reporting) CIK: 0001675758 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39468 | Film No.: 241407078